These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33273570)

  • 1. Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis.
    Taubmann J; Krishnacoumar B; Böhm C; Faas M; Müller DIH; Adam S; Stoll C; Böttcher M; Mougiakakos D; Sonnewald U; Hofmann J; Schett G; Krönke G; Scholtysek C
    Sci Rep; 2020 Dec; 10(1):21020. PubMed ID: 33273570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo.
    Baek JM; Kim JY; Yoon KH; Oh J; Lee MS
    Int J Biol Sci; 2016; 12(5):478-88. PubMed ID: 27019631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
    Hughes A; Rogers MJ; Idris AI; Crockett JC
    Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
    Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
    Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-osteopontin monoclonal antibody prevents ovariectomy-induced osteoporosis in mice by promotion of osteoclast apoptosis.
    Zhang B; Dai J; Wang H; Wei H; Zhao J; Guo Y; Fan K
    Biochem Biophys Res Commun; 2014 Sep; 452(3):795-800. PubMed ID: 25201732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
    Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
    J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic reprogramming in osteoclasts.
    Park-Min KH
    Semin Immunopathol; 2019 Sep; 41(5):565-572. PubMed ID: 31552471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
    Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib prevents ovariectomy-induced osteoporosis in mice by inhibiting osteoclast differentiation.
    Kim SH; Kim MO; Kim HJ; Neupane S; Kim HJ; Lee JH; Kim HH; Kim JY; Lee Y
    J Bone Miner Metab; 2018 Sep; 36(5):537-546. PubMed ID: 29027021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients.
    Jobke B; Milovanovic P; Amling M; Busse B
    Bone; 2014 Feb; 59():37-43. PubMed ID: 24211427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anacardic acid inhibits RANKL-induced osteoclastogenesis
    Zhao K; Jia Y; Peng J; Pang C; Zhang T; Han W; Jiang J; Lu X; Zhu J; Qian Y
    FASEB J; 2019 Aug; 33(8):9100-9115. PubMed ID: 31050917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
    Hsieh TP; Sheu SY; Sun JS; Chen MH
    Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both aerobic glycolysis and mitochondrial respiration are required for osteoclast differentiation.
    Li B; Lee WC; Song C; Ye L; Abel ED; Long F
    FASEB J; 2020 Aug; 34(8):11058-11067. PubMed ID: 32627870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate dehydrogenase A inhibition prevents RANKL-induced osteoclastogenesis by reducing enhanced glycolysis.
    Nishioku T; Anzai R; Hiramatsu S; Terazono A; Nakao M; Moriyama M
    J Pharmacol Sci; 2023 Dec; 153(4):197-207. PubMed ID: 37973217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitors.
    Van 't Hof RJ; Idris AI; Ridge SA; Dunford J; Greig IR; Ralston SH
    J Bone Miner Res; 2004 Oct; 19(10):1651-60. PubMed ID: 15355560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PP121 suppresses RANKL-Induced osteoclast formation in vitro and LPS-Induced bone resorption in vivo.
    Zhou Z; Chen X; Chen X; Qin A; Mao Y; Pang Y; Yu S; Zhang S
    Exp Cell Res; 2020 Mar; 388(2):111857. PubMed ID: 31972221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of
    Madel MB; Ibáñez L; Ciucci T; Halper J; Rouleau M; Boutin A; Hue C; Duroux-Richard I; Apparailly F; Garchon HJ; Wakkach A; Blin-Wakkach C
    Elife; 2020 May; 9():. PubMed ID: 32400390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milk-Derived Nanoparticle Fraction Promotes the Formation of Small Osteoclasts But Reduces Bone Resorption.
    Oliveira MC; Di Ceglie I; Arntz OJ; van den Berg WB; van den Hoogen FH; Ferreira AV; van Lent PL; van de Loo FA
    J Cell Physiol; 2017 Jan; 232(1):225-33. PubMed ID: 27138291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
    Liu FL; Chen CL; Lai CC; Lee CC; Chang DM
    Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitor RepSox prevented ovariectomy-induced osteoporosis by suppressing osteoclast differentiation and bone resorption.
    Mei L; Sang W; Chen Z; Zheng L; Jin K; Lou C; Huang W; He D
    J Cell Physiol; 2018 Dec; 233(12):9724-9738. PubMed ID: 30059597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.